HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

Abstract
The interleukin (IL)-13 receptor alpha2 (IL-13Ralpha2) chain is a primary binding and internalization subunit for a Th2-derived immune regulatory cytokine, IL-13. Although extremely high levels of IL-13Ralpha2 chain are expressed on a variety of human tumor cells and specimens, its precise role in tumor immunology has not been defined. To investigate the role of IL-13Ralpha2 in tumor immunity, we used D5 melanoma cells stably transfected with the human IL-13Ralpha2 gene (D5alpha2) to assess the effect of an IL-13Ralpha2 DNA vaccine in immunocompetent animals. Prophylactic immunization of mice with the IL-13Ralpha2 DNA vaccine resulted in protection against D5alpha2 tumor development. In vivo depletion experiments in C57BL/6 and RAG-2 knockout mice indicated that both T and B cells, but not natural killer cells, were required for the tumor protection. In addition, antibody induced by the IL-13Ralpha2 DNA vaccine showed a modest but significant inhibitory effect on D5alpha2 cells in vitro, suggesting that the antibody is biologically functional. The IL-13Ralpha2 DNA vaccine also exhibited antitumor activity against established D5alpha2 tumors in mice. Histologic analysis of regressing tumors identified infiltration of CD4+ and CD8+ T cells and the expression of CXCL9 chemokine in tumors. Taken together, our results identify the human IL-13Ralpha2 chain as a novel tumor rejection antigen.
AuthorsKoji Kawakami, Masaki Terabe, Mariko Kawakami, Jay A Berzofsky, Raj K Puri
JournalCancer research (Cancer Res) Vol. 66 Issue 8 Pg. 4434-42 (Apr 15 2006) ISSN: 0008-5472 [Print] United States
PMID16618770 (Publication Type: Journal Article, Research Support, N.I.H., Intramural)
Chemical References
  • Antibodies, Neoplasm
  • Cancer Vaccines
  • IL13RA1 protein, human
  • Il13ra1 protein, mouse
  • Interleukin-13 Receptor alpha1 Subunit
  • Receptors, Interleukin
  • Receptors, Interleukin-13
  • Vaccines, DNA
Topics
  • Animals
  • Antibodies, Neoplasm (biosynthesis, immunology)
  • B-Lymphocytes (immunology)
  • CD4-Positive T-Lymphocytes (immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • Cancer Vaccines (administration & dosage, genetics, immunology)
  • Female
  • Humans
  • Interleukin-13 Receptor alpha1 Subunit
  • Killer Cells, Natural (immunology)
  • Melanoma, Experimental (genetics, immunology, prevention & control, therapy)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Receptors, Interleukin (genetics, immunology)
  • Receptors, Interleukin-13
  • T-Lymphocytes, Cytotoxic (immunology)
  • Transfection
  • Vaccination (methods)
  • Vaccines, DNA (administration & dosage, genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: